Only Phlebotomists with at least 12 months practical experience will be considered.Relief PhlebotomistThe hourly rate for this role is £12.36 and up to £13.53 across selected locations within London.By joining our team, you will be working on behalf of Our Future Health, a charity in partnership with the NHS and aiming to become the UK's largest ever health research programme.
Travel expenses are covered by Boots.A full driving licence and access to a car are necessary in this role due to the supporting other stores.
The Relief Phlebotomist role will involve travelling to stores around the region up to 60 minutes from base store.
Join the CAMHS team at Rhodes Wood Hospital as an Associate Specialist/Specialty Doctor and deliver high-quality clinical service across an eating disorder service under the direction of the responsible clinicians.
Working 37.5 hours a week, you will take a specific focus on physical health, food and fluids and risk management across the ward working closely with the Consultant, ward manager, and wider MDT.
In this role, you will provide clinical assessment, review, and evaluation to young people under the care and treatment of the hospital ensuring that all treatment plans are fully adhered to.
Posted by Randox Laboratories • £28K/yr to £30K/yr
Phlebotomist - Great Portland Street - (Job Ref: 24/GPST)
Randox Health continues to be at the forefront of clinical diagnostics, dedicated to improving health worldwide with our disruptive technology and innovative diagnostic solutions.
Our staff are at the heart of everything we do and achieve.
Front of House PorterLocation: The Wellington Hospital, St Johns Wood, LondonPermanentFull time 37.5 Hours per week Monday to Sunday, shifts between 07:00 and 19:00£25,642 per annum fantastic benefits
PLEASE NOTE, A FULL UK DRIVERS LICENSE IS ESSENTIAL
We're looking for a Front of House Porter to join the team at The Wellington Hospital, currently the largest private hospital in the UK.
About the Trial: Our Client is conducting a significant clinical trial to investigate the effects of oral semaglutide versus placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Study treatments will be sent to participants' homes by post.
Participants will take part remotely by completing questionnaires on their own devices or during telephone interviews with research nurses.